novo 14 Pill - white oval, 14mm
Generic Name: semaglutide
Pill with imprint novo 14 is White, Oval and has been identified as Rybelsus (formulation R1) 14 mg. It is supplied by Novo Nordisk.
Rybelsus is used in the treatment of Type 2 Diabetes and belongs to the drug class GLP-1 Agonists (Incretin Mimetics). Rybelsus 14 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for novo 14


Rybelsus (formulation R1)
- Generic Name
- semaglutide
- Imprint
- novo 14
- Strength
- 14 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- GLP-1 Agonists (Incretin Mimetics)
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novo Nordisk
- National Drug Code (NDC)
- 00169-4314
See also:
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Levemir
Levemir (insulin detemir) is a long acting insulin used to treat diabetes in adults and children ...
Basaglar
Basaglar (insulin glargine) is a long-acting insulin that is used to improve blood sugar control in ...
Novolog
NovoLog is a fast-acting insulin used to treat diabetes to control blood sugar levels in adults and ...
Toujeo SoloStar
Toujeo (insulin glargine) is an injection used to treat type 1 or type 2 diabetes. Includes Toujeo ...
More about Rybelsus (semaglutide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (297)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: GLP-1 Agonists (Incretin Mimetics)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.